Company Search:
Advanced Search
Sponsored Links
Pharmaxis Ltd Company Snapshot
Pharmaxis Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other companies in this sector in Australia: Clinuvel Pharmaceuticals Limited (2017 sales of 17.03 million Australian Dollars [US$13.47 million] of which 100% was Biotechnology), Bionomics Limited (18.61 million Australian Dollars [US$14.72 million] of which 88% was Drug discovery and development), and Xrf Scientific Ltd (21.54 million Australian Dollars [US$17.04 million] of which 40% was Precious Metals).

Sales Analysis. During the year ended June of 2017, sales at Pharmaxis Ltd were A$17.64 million (US$13.95 million). This is a decrease of 5.0% versus 2016, when the company's sales were A$18.57 million. Contributing to the drop in overall sales was the 9.2% decline in Bronchitol and Aridol, from A$14.91 million to A$13.54 million. . However, these declines were partially offset by the increase in sales of New Drug Development (up 32.4% to A$3.42 million) and Corporate (up 6.3% to A$337,000.00 ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharmaxis Ltd
  Stock Performance Chart for Pharmaxis Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): .28
(Figures in Australian Dollars)
1 Week 3.8%   13 Weeks 7.8%  
4 Weeks 5.8%   52 Weeks -1.8%  
Pharmaxis Ltd Key Data:
  Ticker: PXS Country: Australia
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 17,638,000
(Year Ending Jan 2018).
Employees: 107
  Currency: Australian Dollars Market Cap: 87,754,382
  Fiscal Yr Ends: June Shares Outstanding: 319,106,844
  Share Type: Ordinary Closely Held Shares: 47,170,947
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.